Tiannan Guo
郭天南
Tiannan Guo is a proteomics researcher and founder of Westlake Omics, a Hangzhou-based startup applying AI to proteomics data for disease diagnosis and drug discovery . He serves as a specially appointed researcher at Westlake University's School of Life Sciences and directs the iMarker Lab at Westlake Laboratory . His academic training was under Swiss professor Ruedi Aebersold, a leading figure in the field . Westlake Omics raised seed funding in the tens of millions of RMB in 2021 and followed with a pre-A round in the hundreds of millions of RMB in early 2022, with Gaorong Capital backing both rounds .
AI-generated — may contain errors, please verify.
Coverage
Medtech Entrepreneurship Is a "Game for the Brave": How to Sharpen Innovation, Product, and Organizational Capabilities | Ronghui
Discussing trends in medical technology innovation and upgrading R&D team organizational management.
Securing Hundreds of Millions of Yuan in Pre-A Funding, How Westlake Omics Builds the AlphaFold of Proteomics | Gaorong "Future"
Deciphering the mathematical laws of the microscopic protein world to enable proteomics-based precision medicine.
Westlake Omics completes tens of millions of RMB in seed funding to advance proteomics research and precision-assisted diagnostics
Dedicated to realizing proteomics-based precision medicine, advancing auxiliary diagnosis of major human diseases.
